Insights into the reaction of protein-tyrosine phosphatase 1B: crystal structures for transition state analogs of both catalytic steps
- PMID: 20236928
- PMCID: PMC2871455
- DOI: 10.1074/jbc.M109.066951
Insights into the reaction of protein-tyrosine phosphatase 1B: crystal structures for transition state analogs of both catalytic steps
Abstract
Catalysis by protein-tyrosine phosphatase 1B (PTP1B) occurs through a two-step mechanism involving a phosphocysteine intermediate. We have solved crystal structures for the transition state analogs for both steps. Together with previously reported crystal structures of apo-PTP1B, the Michaelis complex of an inactive mutant, the phosphoenzyme intermediate, and the product complex, a full picture of all catalytic steps can now be depicted. The transition state analog for the first catalytic step comprises a ternary complex between the catalytic cysteine of PTP1B, vanadate, and the peptide DADEYL, a fragment of a physiological substrate. The equatorial vanadate oxygen atoms bind to the P-loop, and the apical positions are occupied by the peptide tyrosine oxygen and by the PTP1B cysteine sulfur atom. The vanadate assumes a trigonal bipyramidal geometry in both transition state analog structures, with very similar apical O-O distances, denoting similar transition states for both phosphoryl transfer steps. Detailed interactions between the flanking peptide and the enzyme are discussed.
Figures





Similar articles
-
The catalytic scaffold of the haloalkanoic acid dehalogenase enzyme superfamily acts as a mold for the trigonal bipyramidal transition state.Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5687-92. doi: 10.1073/pnas.0710800105. Epub 2008 Apr 8. Proc Natl Acad Sci U S A. 2008. PMID: 18398008 Free PMC article.
-
Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase.Structure. 2005 Nov;13(11):1643-51. doi: 10.1016/j.str.2005.07.019. Structure. 2005. PMID: 16271887
-
Evaluating transition state structures of vanadium-phosphatase protein complexes using shape analysis.J Inorg Biochem. 2015 Jun;147:153-64. doi: 10.1016/j.jinorgbio.2015.04.005. Epub 2015 Apr 17. J Inorg Biochem. 2015. PMID: 25953100
-
The power of vanadate in crystallographic investigations of phosphoryl transfer enzymes.FEBS Lett. 2004 Nov 19;577(3):315-21. doi: 10.1016/j.febslet.2004.10.022. FEBS Lett. 2004. PMID: 15556602 Review.
-
Recent Advances in Protein Tyrosine Phosphatase 1B Targeted Drug Discovery for Type II Diabetes and Obesity.Curr Drug Targets. 2018;19(5):551-575. doi: 10.2174/1389450118666170222143739. Curr Drug Targets. 2018. PMID: 28228082 Review.
Cited by
-
Catalytic scaffolds for phosphoryl group transfer.Curr Opin Struct Biol. 2016 Dec;41:172-179. doi: 10.1016/j.sbi.2016.07.017. Epub 2016 Aug 13. Curr Opin Struct Biol. 2016. PMID: 27526404 Free PMC article. Review.
-
Synthesis, In Vitro, and Computational Studies of PTP1B Phosphatase Inhibitors Based on Oxovanadium(IV) and Dioxovanadium(V) Complexes.Int J Mol Sci. 2022 Jun 24;23(13):7034. doi: 10.3390/ijms23137034. Int J Mol Sci. 2022. PMID: 35806035 Free PMC article.
-
Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.Biol Trace Elem Res. 2019 Mar;188(1):68-98. doi: 10.1007/s12011-018-1540-6. Epub 2018 Oct 22. Biol Trace Elem Res. 2019. PMID: 30350272 Free PMC article. Review.
-
Untargeted Metabolomics Approach for the Discovery of Environment-Related Pyran-2-ones Chemodiversity in a Marine-Sourced Penicillium restrictum.Mar Drugs. 2021 Jun 29;19(7):378. doi: 10.3390/md19070378. Mar Drugs. 2021. PMID: 34210084 Free PMC article.
-
Significant Loop Motions in the SsoPTP Protein Tyrosine Phosphatase Allow for Dual General Acid Functionality.Biochemistry. 2021 Sep 28;60(38):2888-2901. doi: 10.1021/acs.biochem.1c00365. Epub 2021 Sep 8. Biochemistry. 2021. PMID: 34496202 Free PMC article.
References
-
- Barford D., Das A. K., Egloff M. P. (1998) Annu. Rev. Biophys. Biomol. Struct. 27, 133–164 - PubMed
-
- Zhang Z. Y. (1998) Crit. Rev. Biochem. Mol. Biol. 33, 1–52 - PubMed
-
- Alonso A., Sasin J., Bottini N., Friedberg I., Friedberg I., Osterman A., Godzik A., Hunter T., Dixon J., Mustelin T. (2004) Cell 117, 699–711 - PubMed
-
- Hunter T. (2000) Cell 100, 113–127 - PubMed
-
- Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A. L., Normandin D., Cheng A., Himms-Hagen J., Chan C. C., Ramachandran C., Gresser M. J., Tremblay M. L., Kennedy B. P. (1999) Science 283, 1544–1548 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous